Sequencing Systems

Thermo Fisher Scientific Genetic Analyzers Comply with IVDR Regulations

Thermo Fisher Scientific has updated its Applied Biosystems 3500 and 3500xL DX genetic analyzers to comply with IVDR regulations.

Sequencing Systems

Brain Tumor Diagnosis Is Changing Due to Genomic Sequencing

A study by UC San Francisco underscores the critical role of genomic profiling in brain tumor diagnosis and grading.

Sequencing Systems

Singular Genomics Launches Next-Gen Sequencing Platform

Singular Genomics Systems launched its G4 benchtop sequencer for commercial use in a range of applications, such as research in oncology and immunology.

Genetic Testing Could Reduce Rare Pediatric Cancer Deaths by Half

Oct 28, 2021 | Sequencing Systems, Unknown Origin & Other Cancer Types

Genetic testing of the siblings of newborns with cancer genes could reduce rare pediatric cancer deaths by about 50%, an NIH-funded analysis suggests.

In The DNA: Shortcut to Identify Pathogens Found

Sep 16, 2021 | Sepsis, Sequencing Systems

Researchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.

INanoBio Takes a Step Closer to Ultra-Fast DNA Sequencing

Sep 7, 2021 | Sequencing Systems

INanoBio has successfully fabricated initial prototypes of its novel Field Effect Nanopore Transistor (FENT) device.

NuProbe Global and Bionano Team to Co-Develop Testing Products

Sep 2, 2021 | Sequencing Systems

NuProbe Global and Bionano Genomics have entered into a procurement and collaboration agreement, for research and product development.

Rapid Sequencing Diagnoses Ailing Baby in 13 Hours

Jul 27, 2021 | Sequencing Systems

Remarkably, rapid sequencing identified the baby’s rare disease within hours and even pointed to a life-saving treatment, reports STAT News.

New Genotyping Assay Will Allow For More Diverse Genetic Testing

Jun 14, 2021 | Sequencing Systems, Uncategorized

Twist Bioscience Corporation has collaborated with RGC for the production of a custom NGS population genetics genotyping assay.

Quantgene Demonstrates Sequencing Precision in Scientific Journal

Jun 10, 2021 | Sequencing Systems

With accuracy exceeding 1 mutant in 1,000 wild type DNA fragments, the publication showcases the power of Quantgene’s new cloud and AI technology in cancer detection systems.

First Approval of Diagnostic NGS Platforms in Russia

Mar 11, 2021 | Sequencing Systems

Illumina’s NextSeq 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeqDx.

Veracyte to Acquire Decipher Biosciences

Feb 5, 2021 | Company News, Prostate, Sequencing Systems, Unknown Origin & Other Cancer Types

Decipher’s comprehensive portfolio of tests in urologic cancers leverage whole transcriptome analysis and proprietary machine learning algorithms to improve patient decision-making.

New Bioinformatics Solution Powers Multi-Omics Discovery

Jan 13, 2021 | Sequencing Systems

Illumina Connected Analytics provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.

New England Biolabs Introduces Toolset for Customizable RNA Depletion

Dec 11, 2020 | Sequencing Systems

Together, the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent Set enable a fully customizable workflow for improved removal of specific RNAs.